The Pennant Group, Inc. (NASDAQ:PNTG) Shares Sold by Crewe Advisors LLC

Crewe Advisors LLC lessened its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 97.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,750 shares of the company’s stock after selling 726,208 shares during the period. Crewe Advisors LLC’s holdings in The Pennant Group were worth $444,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. The Manufacturers Life Insurance Company raised its holdings in shares of The Pennant Group by 4.4% in the second quarter. The Manufacturers Life Insurance Company now owns 11,227 shares of the company’s stock valued at $260,000 after buying an additional 471 shares during the last quarter. Creative Planning increased its stake in The Pennant Group by 2.0% in the 2nd quarter. Creative Planning now owns 19,152 shares of the company’s stock valued at $444,000 after buying an additional 373 shares during the period. SG Americas Securities LLC purchased a new position in The Pennant Group during the 3rd quarter worth $390,000. USA Financial Formulas purchased a new stake in shares of The Pennant Group in the third quarter valued at about $121,000. Finally, Kings Path Partners LLC acquired a new position in shares of The Pennant Group during the third quarter worth about $277,000. Hedge funds and other institutional investors own 85.88% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on PNTG. Truist Financial reduced their price objective on shares of The Pennant Group from $38.00 to $32.00 and set a “hold” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company initiated coverage on The Pennant Group in a report on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price target for the company. Royal Bank of Canada increased their target price on shares of The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a report on Wednesday, October 23rd. Oppenheimer boosted their target price on The Pennant Group from $34.00 to $37.00 and gave the stock an “outperform” rating in a research report on Friday, November 8th. Finally, Stephens reaffirmed an “overweight” rating and set a $40.00 price target on shares of The Pennant Group in a research note on Wednesday, October 9th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $36.00.

The Pennant Group Stock Performance

NASDAQ PNTG opened at $28.35 on Thursday. The Pennant Group, Inc. has a fifty-two week low of $14.84 and a fifty-two week high of $37.13. The stock has a market cap of $973.82 million, a price-to-earnings ratio of 41.69, a price-to-earnings-growth ratio of 2.35 and a beta of 1.92. The business has a fifty day moving average of $27.97 and a 200-day moving average of $30.96. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58.

The Pennant Group Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.